Lascco
Company Team Projects Media Contact
Management
Scientific Advisory Board
Board of Directors


MANAGEMENT

Frederic Lajaunias

Frédéric Lajaunias (Co-founder and Managing Director)
Frédéric has 9 year experience in early stage development. Since he co-founded LASCCO SA in 2007, Frédéric managed the development of discovery-stage pharmaceuticals and diagnostics in the field of infectious diseases, autoimmune diseases and oncology, leading to the creation of LASCCO's spin-offs Combioxin SA and Sepstone Diagnostics SARL. Prior to founding LASCCO SA, Frédéric served at Abbott Laboratories as manager for the Swiss virology division. Before that, he carried out a post-doctoral work at the Geneva University Hospital studying autoimmune disorders. Frédéric holds a PhD in Immunology from the University of Paris VII, and an MBA from the University of Geneva.

Samareh Lajaunias

Samareh Lajaunias Azeredo da Silveira (Co-founder and Managing Director)
Samareh is an early-stage drug development specialist. Since she co-founded LASCCO SA in 2007, Samareh managed the development of various discovery-stage projects in the field of infectious diseases (leading to the creation of LASCCO's spin-offs Combioxin SA and Sepstone Diagnostics SARL), gene therapy, and neuroinflammatory disorders. Samareh holds a PhD in Neurosciences from Ecole Polytechnique Fédérale de Lausanne (EPFL) – laboratory of Prof. Patrick Aebischer - and obtained a Master's degree in Immunology at the  University of Geneva. Her work led to the publication of several articles in peer-reviewed journals.
Lascco